Sumatriptan succinate

Also known as: Sumatriptan succinate (1:1), GR 43175, Imitrex, Imigran, SuMitrex, 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide succinate, 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide butanedioate (1:1), Butanedioic acid, compd. with 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide (1:1), MFCD00866222, SuMatriptan Succinate, EP

Sumatriptan succinate (CAS 103628-48-4) is a compound in the Organic Acids category listed in the Jingsj chemical database. It has the molecular formula C18H27N3O6S and a molecular weight of 413.49400 g/mol. Key properties include a melting point of 165-166°C, a boiling point of 497.7ºC at 760 mmHg, a density of 1.2±0.1 g/cm3 and a flash point of 254.8ºC. It is classified under GHS with signal word Danger and hazard statements H318 — Causes serious eye damage. No supplier offers are currently listed; request a quote. Record last updated Nov 2, 2026.

CAS No.: 103628-48-4
Jingsj CID: J-25046-4
Molecular Formula: C₁₈H₂₇N₃O₆S
Molecular Weight: 413.49400 g/mol
Category: Organic Acids
Last updated: 11/2/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	165-166°C
Boiling Point	497.7ºC at 760 mmHg
Density	1.2±0.1 g/cm3
Flash Point	254.8ºC
Exact Mass	341.140930
PSA	148.18000
LogP	0.34
Vapor Pressure	1.24E-17mmHg at 25°C
Refractive Index	1.552
Storage Conditions	Store at +4°C

GHS Safety & Compliance

CorrosionSignal word: Danger

H318 — Causes serious eye damage

Activity & Biological Data

Additional Information	[1]. Dechant KL, et al. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. [2]. Derry CJ, et al. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012 Feb 15;2:CD008615. [3]. Depré M, et al. Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine. Cephalalgia. 2013 Dec;33(16):1292-301.

Additional Information

[1]. Dechant KL, et al. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. [2]. Derry CJ, et al. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012 Feb 15;2:CD008615. [3]. Depré M, et al. Lack of hemodynamic interaction between CGRP-receptor antagonist telcagepant (MK-0974) and sumatriptan: results from a randomized study in patients with migraine. Cephalalgia. 2013 Dec;33(16):1292-301.

Customs & Trade Information

HS Code	2935009090
Summary	2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%

Frequently Asked Questions

What is the CAS number of Sumatriptan succinate?

The CAS number of Sumatriptan succinate is 103628-48-4.

What are the molecular formula and molecular weight of Sumatriptan succinate?

Sumatriptan succinate has molecular formula C18H27N3O6S and molecular weight 413.49400 g/mol.

Is Sumatriptan succinate hazardous?

Sumatriptan succinate has GHS signal word Danger and hazard statements H318 — Causes serious eye damage.

What are the upstream and downstream products of Sumatriptan succinate?

For Sumatriptan succinate, Upstream Products: Sumatriptan, Succinic acid; Downstream Products: Sumatriptan.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 11/2/2026

How to cite: Jingsj. "Sumatriptan succinate (CAS 103628-48-4)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-25046-4 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.